These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The probability of blindness in patients treated for glaucoma. Chang LC; Teng MC; Chang HW; Lai IC; Lin PW; Tsai JC Chang Gung Med J; 2005 Jul; 28(7):492-7. PubMed ID: 16231533 [TBL] [Abstract][Full Text] [Related]
23. Angle closure glaucoma: a cause for bilateral visual threat. Shakya S; Gupta HR Nepal Med Coll J; 2006 Sep; 8(3):153-5. PubMed ID: 17203819 [TBL] [Abstract][Full Text] [Related]
24. [Glaucoma: modern diagnostic and therapeutic approach]. Mermoud A Rev Med Suisse Romande; 1998 Jan; 118(1):81-4. PubMed ID: 9528328 [TBL] [Abstract][Full Text] [Related]
25. Glaucoma blindness at the end of life. Mokhles P; Schouten JS; Beckers HJ; Azuara-Blanco A; Tuulonen A; Webers CA Acta Ophthalmol; 2017 Feb; 95(1):10-11. PubMed ID: 28102642 [No Abstract] [Full Text] [Related]
26. Assessing glaucoma's risk factors. During initial screening, signs of damage to the optic nerve could be more reliable indicators of the disease. Health News; 2005 Jan; 11(1):10-1. PubMed ID: 15726711 [No Abstract] [Full Text] [Related]
28. Lifetime visual disability in open-angle glaucoma and ocular hypertension. Forsman E; Kivelä T; Vesti E J Glaucoma; 2007 May; 16(3):313-9. PubMed ID: 17438426 [TBL] [Abstract][Full Text] [Related]
29. Glaucoma screening in the elderly. Hitchings RA Curr Med Res Opin; 1982; 7(Suppl 1):23-7. PubMed ID: 7105792 [TBL] [Abstract][Full Text] [Related]
30. Glaucoma: an overview. Sivalingam E J Ophthalmic Nurs Technol; 1996; 15(1):15-8. PubMed ID: 8715021 [TBL] [Abstract][Full Text] [Related]
31. [Causes of blindness in Israel]. Hod Y; Corcia Y; Yassur Y; Geyer O Harefuah; 2000 Feb; 138(4):276-8, 342. PubMed ID: 10883109 [TBL] [Abstract][Full Text] [Related]
32. [Prevention of blindness from primary glaucoma]. Luchik VI Feldsher Akush; 1983; 48(1):38-9. PubMed ID: 6549996 [No Abstract] [Full Text] [Related]
33. [Selection of treatment modality for developmental glaucoma]. Yang GH Zhonghua Yan Ke Za Zhi; 1989 Mar; 25(2):88-9. PubMed ID: 2507259 [TBL] [Abstract][Full Text] [Related]
34. [Synthesis of the blindness situation in the countries of the Organization for Cooperation and Coordination in the Control of Major Endemic Diseases]. Auzemery A; Ceccon JF; Ducousso F; Huguet P; Traoré J; Audugé A; Diallo A; Schémann JF Sante; 1998; 8(2):138-40. PubMed ID: 9642738 [TBL] [Abstract][Full Text] [Related]
35. Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates? Merritt JC J Natl Med Assoc; 1996 Dec; 88(12):809-19. PubMed ID: 8990808 [No Abstract] [Full Text] [Related]
36. [Strategies to control glaucoma]. Ceccon JF; Auzemery A; Audugé A; Ducousso F; Schémann JF; Eddine SA Sante; 1998; 8(2):157-8. PubMed ID: 9642743 [No Abstract] [Full Text] [Related]
37. Monograph series on aging-related diseases: XI. Glaucoma. Elolia R; Stokes J Chronic Dis Can; 1998; 19(4):157-69. PubMed ID: 10029512 [TBL] [Abstract][Full Text] [Related]
38. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Xu L; Wang Y; Li Y; Wang Y; Cui T; Li J; Jonas JB Ophthalmology; 2006 Jul; 113(7):1134.e1-11. PubMed ID: 16647133 [TBL] [Abstract][Full Text] [Related]